4.14
Can-Fite Biopharma Ltd ADR-Aktien (CANF) Preisverlauf
Täglich
Wöchentlich
Monatlich
7T
30T
60T
YTD
1J
| Datum | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2026-01-09 | $4.40 | $4.14 | $0.26 | 38,661.0 | -5.05% |
| 2026-01-08 | $4.74 | $4.12 | $0.6117 | 99,823.0 | -7.43% |
| 2026-01-07 | $4.85 | $4.00 | $0.8499 | 203,361.0 | +18.34% |
| 2026-01-06 | $4.17 | $3.63 | $0.54 | 215,835.0 | -7.23% |
| 2026-01-05 | $4.59 | $4.00 | $0.5905 | 175,192.0 | -2.50% |
| 2026-01-02 | $4.40 | $3.72 | $0.68 | 134,061.8 | +10.00% |
| 2025-12-31 | $4.05 | $3.58 | $0.47 | 185,102.8 | +8.99% |
| 2025-12-30 | $3.99 | $3.38 | $0.614 | 212,766.0 | +7.00% |
| 2025-12-29 | $4.20 | $3.36 | $0.844 | 315,227.8 | -19.82% |
| 2025-12-26 | $5.47 | $4.20 | $1.27 | 8,738,830.8 | +18.64% |
| 2025-12-24 | $4.05 | $3.40 | $0.646 | 189,190.3 | -25.03% |
| 2025-12-23 | $5.02 | $4.67 | $0.352 | 49,098.8 | -1.72% |
| 2025-12-22 | $5.16 | $4.80 | $0.364 | 49,001.0 | -2.94% |
| 2025-12-19 | $5.18 | $4.90 | $0.278 | 36,486.2 | +0.84% |
| 2025-12-18 | $5.39 | $4.91 | $0.48 | 83,221.7 | -8.63% |
| 2025-12-17 | $5.84 | $5.40 | $0.44 | 31,004.9 | -5.33% |
| 2025-12-16 | $6.10 | $5.30 | $0.798 | 81,931.6 | +9.06% |
| 2025-12-15 | $5.90 | $5.20 | $0.696 | 31,638.1 | -6.29% |
| 2025-12-12 | $5.98 | $5.64 | $0.336 | 31,176.9 | -2.18% |
| 2025-12-11 | $6.20 | $5.70 | $0.498 | 38,022.2 | -6.74% |
Can-Fite Biopharma Ltd ADR-Aktien (CANF) Preisverlauf Jahr für Jahr
In dieser detaillierten Analyse präsentieren wir einen umfassenden Überblick über die Kursbewegungen der Can-Fite Biopharma Ltd ADR-Aktie im Laufe der Jahre. Durch die Untersuchung der Jahresdaten können Investoren wertvolle Einblicke in die historische Performance und Volatilität der CANF-Aktien gewinnen. Von bedeutenden Meilensteinen und Schwankungen bis hin zu bemerkenswerten Trends bietet diese gründliche Untersuchung der Preisgeschichte der Can-Fite Biopharma Ltd ADR-Aktie eine Grundlage für das Verständnis der Entwicklung der Aktien des Unternehmens im Laufe der Zeit.
Can-Fite Biopharma Ltd ADR-Aktien (CANF) Preisverlauf 2026
| Monat | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2026-01 | $4.85 | $3.63 | $1.22 | 905,594.8 | +3.50% |
Can-Fite Biopharma Ltd ADR-Aktien (CANF) Preisverlauf 2025
| Monat | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2025-12 | $7.90 | $3.36 | $4.54 | 10,301,505.8 | -47.69% |
| 2025-11 | $12.30 | $5.60 | $6.70 | 19,077,083.4 | -16.99% |
| 2025-10 | $12.73 | $8.30 | $4.43 | 305,985.1 | -31.75% |
| 2025-09 | $13.40 | $11.86 | $1.54 | 167,503.6 | -1.93% |
| 2025-08 | $14.06 | $12.60 | $1.46 | 151,041.7 | -5.75% |
| 2025-07 | $21.00 | $13.15 | $7.85 | 310,748.7 | -36.20% |
| 2025-06 | $23.40 | $20.20 | $3.20 | 136,151.6 | -2.33% |
| 2025-05 | $24.00 | $19.60 | $4.40 | 89,234.2 | -1.38% |
| 2025-04 | $36.40 | $20.50 | $15.90 | 434,038.4 | -26.35% |
| 2025-03 | $46.60 | $28.80 | $17.80 | 349,253.4 | -15.91% |
| 2025-02 | $40.80 | $27.00 | $13.80 | 111,367.0 | +18.92% |
| 2025-01 | $36.80 | $29.00 | $7.80 | 108,036.6 | -8.92% |
Can-Fite Biopharma Ltd ADR-Aktien (CANF) Preisverlauf 2024
| Monat | Hoch | Niedrig | Hoch - Niedrig | Volumen | % Veränderung |
|---|---|---|---|---|---|
| 2024-12 | $47.00 | $25.80 | $21.20 | 1,190,675.9 | -30.00% |
| 2024-11 | $50.00 | $38.00 | $12.00 | 72,915.9 | +2.33% |
| 2024-10 | $62.40 | $38.20 | $24.20 | 117,804.3 | +6.97% |
| 2024-09 | $50.00 | $37.32 | $12.68 | 128,840.2 | -9.46% |
| 2024-08 | $64.80 | $42.00 | $22.80 | 81,771.2 | -30.41% |
| 2024-07 | $93.80 | $46.00 | $47.80 | 146,096.9 | +23.64% |
| 2024-06 | $89.60 | $46.00 | $43.60 | 132,461.9 | +9.33% |
| 2024-05 | $50.00 | $40.00 | $10.00 | 25,952.0 | +14.00% |
| 2024-04 | $54.20 | $38.20 | $16.00 | 21,058.5 | -6.76% |
| 2024-03 | $46.00 | $40.60 | $5.40 | 14,378.1 | +3.74% |
| 2024-02 | $43.60 | $39.80 | $3.80 | 19,787.5 | +1.42% |
| 2024-01 | $45.40 | $37.40 | $8.00 | 24,587.1 | -4.09% |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):